Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...
Sarepta Therapeutics saw its stock skid 11% after the company announced preliminary unaudited 2025 sales results that missed analyst forecasts for its marketed Elevidys® (delandistrogene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback